Levocetirizina Glenmark

Levocetirizine, the active ingredient in Levocetirizina Glenmark, is a second‑generation antihistamine presented as an oral tablet for oral use. It alleviates symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children when prescribed by a healthcare professional. It is indicated for the relief of itching, sneezing, watery eyes and nasal congestion associated with these conditions.

GNH USA supplies Levocetirizina Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with capabilities for bulk manufacturing, quality assurance and regulatory compliance.

Levocetirizine is a second‑generation antihistamine that reduces histamine‑mediated allergic responses. - Allergic rhinitis: reduces sneezing, itching, nasal discharge and congestion. - Chronic idiopathic urticaria: relieves hives and associated itching. - Seasonal allergic rhinitis: controls symptoms during pollen exposure.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness: mild to moderate sleepiness. - Dry mouth: reduced salivation. - Headache: transient cranial discomfort. - Nausea: mild gastrointestinal upset. - Fatigue: feeling of reduced energy. - Abdominal pain: mild stomach discomfort.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat. - Anaphylaxis: severe, life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin eruption. - Hepatic enzyme elevation: abnormal liver function tests. - Blood dyscrasias: rare blood count abnormalities. - Cardiac arrhythmia: irregular heartbeat in susceptible individuals.

Before initiating therapy, consider the following safety measures. - Renal or hepatic impairment: adjust dose or monitor closely. - Pregnancy: use only if clearly needed after risk assessment. - Breastfeeding: evaluate potential exposure to infant. - Sedation: avoid operating machinery if drowsiness occurs. - Concomitant CNS depressants: monitor for additive sedation. - Store at ambient temperature: keep in original packaging, protect from moisture.

Levocetirizine may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase plasma concentrations. - Alcohol or CNS depressants: can enhance drowsiness. - Other antihistamines: additive sedation risk.

Moderate Interactions (Monitor Closely): - Theophylline: may raise levocetirizine levels. - Ritonavir: potential increase in exposure. - Diuretics: may affect drug elimination.